Impact of an educational intervention on pharmacovigilance knowledge and attitudes among health professionals in a Nepal cancer hospital

[1] Pitts PJ(2016)21st century pharmacovigilance: efforts, roles, and responsibilities Lancet Oncol 17 e486-e492

[2] Louet HL(2013)Clinical and economic burden of adverse drug reactions J Pharmacol Pharmacother 4 S73-S77

[3] Moride Y(2014)Adherence to therapy and adverse drug reactions: is there a link? Expert Opin Drug Saf 13 41-55

[4] Conti RM(2019)Healthcare professionals’ pharmacovigilance knowledge and adverse drug reaction reporting behavior and factors determining the reporting rates J Drug Assess 8 13-20

[5] Sultana J(2009)Primum non nocere (first, not to harm) and secundus, opinio vulnero (second, report the harm) Int J Pediatr Endocrinol 1 303509-1369

[6] Cutroneo P(2005)Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions Arch Intern Med 165 1363-1089

[7] Trifirò G(2018)Establishment of the first cancer hospital-based pharmacovigilance center in Nepal Res Soc Adm Pharm 14 1088-837

[8] Leporini C(2017)Knowledge, attitude and practices of pharmacovigilance and adverse drug reaction reporting among pharmacists working in secondary and tertiary governmental hospitals in Kuwait Saudi Pharm J 25 830-227

[9] De Sarro G(2013)Impact of training on Nigerian healthcare professionals’ knowledge and practice of pharmacovigilance Int J Risk Saf Med 25 219-235

[10] Russo E(2013)Strengthening the Pharmacovigilance Programme in Nepal Nepal J Epidemiol 3 230-118

[1] Pitts PJ(2016)21st century pharmacovigilance: efforts, roles, and responsibilities Lancet Oncol 17 e486-e492

[2] Louet HL(2013)Clinical and economic burden of adverse drug reactions J Pharmacol Pharmacother 4 S73-S77

[3] Moride Y(2014)Adherence to therapy and adverse drug reactions: is there a link? Expert Opin Drug Saf 13 41-55

[4] Conti RM(2019)Healthcare professionals’ pharmacovigilance knowledge and adverse drug reaction reporting behavior and factors determining the reporting rates J Drug Assess 8 13-20

[5] Sultana J(2009)Primum non nocere (first, not to harm) and secundus, opinio vulnero (second, report the harm) Int J Pediatr Endocrinol 1 303509-1369

[6] Cutroneo P(2005)Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions Arch Intern Med 165 1363-1089

[7] Trifirò G(2018)Establishment of the first cancer hospital-based pharmacovigilance center in Nepal Res Soc Adm Pharm 14 1088-837

[8] Leporini C(2017)Knowledge, attitude and practices of pharmacovigilance and adverse drug reaction reporting among pharmacists working in secondary and tertiary governmental hospitals in Kuwait Saudi Pharm J 25 830-227

[9] De Sarro G(2013)Impact of training on Nigerian healthcare professionals’ knowledge and practice of pharmacovigilance Int J Risk Saf Med 25 219-235

[10] Russo E(2013)Strengthening the Pharmacovigilance Programme in Nepal Nepal J Epidemiol 3 230-118